Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Yu

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.
Urologic Oncology|March 23, 2023
Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinomaFacundo Davaro, Elizabeth Davaro, Kyle Rose, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Urologic Oncology|October 25, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancerRoger Li, Shreyas Naidu, Wenyi Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2021
NAD<sup>+</sup> depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibitionAlexandra M Moore, Lei Zhou, Jing Cui, et al.
The Journal of Urology|November 13, 2025
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality TherapyDekuang Zhao, Vaseem M Khatri, Justyn Y Nakashima, et al.
Genome Biology|May 9, 2020
A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talkAndrew J Gentles, Angela Bik-Yu Hui, Weiguo Feng, et al.
European Urology|February 7, 2012
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan IndexDavid Ulmert, Reza Kaboteh, Josef J Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322AWayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.
Urologic Oncology|March 23, 2023
Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinomaFacundo Davaro, Elizabeth Davaro, Kyle Rose, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Urologic Oncology|October 25, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancerRoger Li, Shreyas Naidu, Wenyi Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2021
NAD<sup>+</sup> depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibitionAlexandra M Moore, Lei Zhou, Jing Cui, et al.
The Journal of Urology|November 13, 2025
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality TherapyDekuang Zhao, Vaseem M Khatri, Justyn Y Nakashima, et al.
Genome Biology|May 9, 2020
A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talkAndrew J Gentles, Angela Bik-Yu Hui, Weiguo Feng, et al.
European Urology|February 7, 2012
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan IndexDavid Ulmert, Reza Kaboteh, Josef J Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322AWayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Pageof 11